🚀 VC round data is live in beta, check it out!
MEDCAMP Valuation Multiples
Discover revenue and EBITDA valuation multiples for MEDCAMP and similar public comparables like Gafisa, CPD, Bolkan Property, ENA and more.
MEDCAMP Overview
About MEDCAMP
MEDCAMP SA is engaged in redevelopment investments. The company provides clients with the quality of development projects prepared for implementation based on revitalized real estates. It also engaged in the acquisition, management, redevelopment and upgrade, as well as rental of commercial properties, including office areas and warehouses.
Founded
1998
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$8M
MEDCAMP Financials
MEDCAMP reported last fiscal year revenue of — and EBITDA of $318K.
In the same fiscal year, MEDCAMP generated $318K in EBITDA and had net loss of ($55K).
MEDCAMP P&L
In the most recent fiscal year, MEDCAMP reported revenue of — and EBITDA of $318K.
MEDCAMP expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | $318K | XXX | XXX | XXX |
| Net Profit | — | XXX | ($55K) | XXX | XXX | XXX |
| Net Debt | — | — | $19K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MEDCAMP Stock Performance
MEDCAMP has current market cap of $8M, and enterprise value of $8M.
Market Cap Evolution
MEDCAMP's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $8M | 0.1% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMEDCAMP Valuation Multiples
MEDCAMP trades at 24.0x EV/EBITDA.
MEDCAMP Financial Valuation Multiples
As of April 20, 2026, MEDCAMP has market cap of $8M and EV of $8M.
Equity research analysts estimate MEDCAMP's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MEDCAMP has a P/E ratio of (143.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 24.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (137.4x) | XXX | XXX | XXX |
| P/E | — | XXX | (143.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (112.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MEDCAMP Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MEDCAMP Margins & Growth Rates
MEDCAMP's revenue in the last fiscal year grew by —.
MEDCAMP Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | (163%) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MEDCAMP Public Comps
See public comps and valuation multiples for other Real Estate Development comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MEDCAMP | XXX | XXX | XXX | XXX | XXX | XXX |
| Gafisa | XXX | XXX | XXX | XXX | XXX | XXX |
| CPD | XXX | XXX | XXX | XXX | XXX | XXX |
| Bolkan Property | XXX | XXX | XXX | XXX | XXX | XXX |
| ENA | XXX | XXX | XXX | XXX | XXX | XXX |
| Wise Finance | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MEDCAMP M&A Activity
MEDCAMP acquired XXX companies to date.
Last acquisition by MEDCAMP was on XXXXXXXX, XXXXX. MEDCAMP acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MEDCAMP
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMEDCAMP Investment Activity
MEDCAMP invested in XXX companies to date.
MEDCAMP made its latest investment on XXXXXXXX, XXXXX. MEDCAMP invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MEDCAMP
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MEDCAMP
| When was MEDCAMP founded? | MEDCAMP was founded in 1998. |
| Where is MEDCAMP headquartered? | MEDCAMP is headquartered in Poland. |
| Is MEDCAMP publicly listed? | Yes, MEDCAMP is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of MEDCAMP? | MEDCAMP trades under MDP ticker. |
| When did MEDCAMP go public? | MEDCAMP went public in 2007. |
| Who are competitors of MEDCAMP? | MEDCAMP main competitors are Gafisa, CPD, Bolkan Property, ENA. |
| What is the current market cap of MEDCAMP? | MEDCAMP's current market cap is $8M. |
| Is MEDCAMP profitable? | No, MEDCAMP is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.